Sif Cosmetics and Ronald L. Moy sign business agreement

Sif Cosmetics and Ronald L. Moy, MD. Inc. have signed a business agreement based on their cooperation on developing anti-aging facial products. The products include growth factors produced by ORF Genetics as active ingredients. Growth factors are proteins that are necessary for stimulating the production and maintenance of cells and have been identified as one of the most exciting breakthroughs in skin-care. Ronald L. Moy, MD. Inc. will start selling the products under its own brand name in its clinics in the USA as early as the third quarter of 2009.

Ronald L. Moy, MD. Inc. is owned by the renowned dr. Ronald Moy, UCLA Medical School professor of Dermatology, Past President of the American Society for Dermatologic Surgery, and President elect of the American Academy of Dermatology. Dr. Moy is the author of numerous books and scientific journal articles on cosmetics and is nationally renowned for his work and has been elected to the Board of Directors of more than five national organizations. Dr. Moy has been named as "One of the Best Doctors in America" in the 1999 edition of The Best Doctors in America.

Sif Cosmetics is an affiliate of ORF Genetics, Icelandic biotech company. Sif offers cosmetic companies a broad portfolio of quality recombinant proteins, active ingredients to promote the biology of hair and skin. Founded in 2009, Sif draws on the development and manufacturing capabilities of its parent company, Orf Genetics. Sif cosmetics currently provides several different cellular activators, formulated in gel.

ORF Genetics Ltd. is a privately owned company. ORF Genetics is an innovative company that is committed to economically viable and enabling solutions for the production of recombinant proteins, such as growth factors and cytokines. Using its exclusive and unique Orfeus™ expression system the company produces growth factors and cytokines under the brand name ISOkine™. The company is approaching the medical scientific research community and the cell culture media and diagnostics market with its products.